Status:
TERMINATED
UVB Phototherapy Treatment of Oral Chronic GVHD
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Dana-Farber Cancer Institute
Conditions:
Oral Chronic Graft-versus-host Disease
Eligibility:
All Genders
4+ years
Phase:
PHASE2
Brief Summary
The purpose of this trial is to find out how effective Narrow Band-Ultraviolet Light B (NB-UVB) phototherapy is in treating oral cGVHD. NB-UVB Phototherapy involves exposing the inside of the mouth to...
Detailed Description
* At the first visit the following information will be collected about the participant: original diagnosis, the date and type of transplant, transplant conditioning regimen, cGVHD prophylaxis regimen,...
Eligibility Criteria
Inclusion
- Patients with oral chronic graft-versus-host disease
- 4 years of age or older
- Stable cGVHD medication regimen for the four weeks prior to study enrollment
Exclusion
- New immunomodulatory medications or increasing dosage of current immunomodulatory medications during the four weeks prior to study enrollment
- Concurrent extracorporeal photopheresis.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00374257
Start Date
August 1 2006
End Date
September 1 2008
Last Update
December 19 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115